Concepts (347)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cognition | 49 | 2023 | 1352 | 7.950 |
Why?
|
| Brain | 40 | 2023 | 1690 | 4.970 |
Why?
|
| White Matter | 11 | 2022 | 142 | 4.750 |
Why?
|
| Aging | 36 | 2023 | 1560 | 4.660 |
Why?
|
| Cognitive Dysfunction | 32 | 2023 | 1035 | 4.080 |
Why?
|
| Aged | 118 | 2023 | 9222 | 3.820 |
Why?
|
| Alzheimer Disease | 30 | 2023 | 2123 | 3.570 |
Why?
|
| Neuropsychological Tests | 61 | 2023 | 1258 | 3.560 |
Why?
|
| Cardiovascular Diseases | 13 | 2023 | 349 | 3.390 |
Why?
|
| Magnetic Resonance Imaging | 38 | 2023 | 1181 | 2.920 |
Why?
|
| Cognition Disorders | 19 | 2020 | 1019 | 2.870 |
Why?
|
| Diffusion Tensor Imaging | 12 | 2023 | 66 | 2.800 |
Why?
|
| Humans | 147 | 2023 | 28054 | 2.640 |
Why?
|
| Female | 103 | 2023 | 15534 | 2.580 |
Why?
|
| Male | 100 | 2023 | 15143 | 2.530 |
Why?
|
| Hypertension | 7 | 2022 | 225 | 2.390 |
Why?
|
| Depression | 8 | 2020 | 452 | 2.260 |
Why?
|
| Executive Function | 21 | 2023 | 116 | 2.200 |
Why?
|
| Middle Aged | 72 | 2023 | 9186 | 2.130 |
Why?
|
| Blood Pressure | 8 | 2022 | 201 | 2.010 |
Why?
|
| Aged, 80 and over | 55 | 2023 | 4846 | 1.960 |
Why?
|
| Verbal Learning | 11 | 2021 | 37 | 1.840 |
Why?
|
| Dementia | 16 | 2023 | 569 | 1.800 |
Why?
|
| Memory Disorders | 7 | 2018 | 168 | 1.770 |
Why?
|
| Acculturation | 3 | 2023 | 37 | 1.760 |
Why?
|
| Diet, Mediterranean | 5 | 2023 | 92 | 1.740 |
Why?
|
| Memory, Short-Term | 11 | 2023 | 104 | 1.720 |
Why?
|
| Connectome | 5 | 2021 | 12 | 1.720 |
Why?
|
| Risk Factors | 26 | 2023 | 2371 | 1.620 |
Why?
|
| Gray Matter | 5 | 2023 | 55 | 1.580 |
Why?
|
| Prefrontal Cortex | 7 | 2016 | 148 | 1.550 |
Why?
|
| Neuroimaging | 10 | 2023 | 133 | 1.510 |
Why?
|
| Health Literacy | 3 | 2023 | 109 | 1.460 |
Why?
|
| Cerebrovascular Disorders | 4 | 2021 | 134 | 1.390 |
Why?
|
| Residence Characteristics | 4 | 2021 | 215 | 1.330 |
Why?
|
| Decision Making | 6 | 2023 | 229 | 1.290 |
Why?
|
| Arteriolosclerosis | 3 | 2023 | 78 | 1.190 |
Why?
|
| Brain Mapping | 10 | 2021 | 168 | 1.190 |
Why?
|
| Public Health | 6 | 2021 | 69 | 1.190 |
Why?
|
| Mental Status and Dementia Tests | 4 | 2021 | 70 | 1.100 |
Why?
|
| United States | 18 | 2021 | 2155 | 1.080 |
Why?
|
| Cohort Studies | 19 | 2023 | 1882 | 1.060 |
Why?
|
| Depressive Disorder | 5 | 2017 | 184 | 1.050 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2018 | 182 | 1.040 |
Why?
|
| Nerve Fibers, Myelinated | 5 | 2013 | 28 | 1.030 |
Why?
|
| Depressive Disorder, Major | 9 | 2018 | 103 | 1.030 |
Why?
|
| Tryptophan | 5 | 2014 | 9 | 1.030 |
Why?
|
| Memory | 10 | 2021 | 309 | 1.010 |
Why?
|
| Apolipoproteins E | 4 | 2023 | 254 | 0.990 |
Why?
|
| Stroke | 5 | 2023 | 272 | 0.960 |
Why?
|
| Cognitive Aging | 3 | 2020 | 79 | 0.960 |
Why?
|
| Exercise | 7 | 2022 | 464 | 0.950 |
Why?
|
| Cross-Sectional Studies | 14 | 2023 | 928 | 0.940 |
Why?
|
| Hippocampus | 9 | 2022 | 281 | 0.930 |
Why?
|
| Educational Status | 5 | 2023 | 292 | 0.910 |
Why?
|
| Psychomotor Performance | 9 | 2020 | 214 | 0.900 |
Why?
|
| Pattern Recognition, Visual | 2 | 2019 | 27 | 0.890 |
Why?
|
| Diabetes Mellitus | 3 | 2020 | 137 | 0.880 |
Why?
|
| Linear Models | 6 | 2020 | 253 | 0.860 |
Why?
|
| Spatial Processing | 2 | 2021 | 7 | 0.860 |
Why?
|
| Mental Recall | 7 | 2020 | 70 | 0.830 |
Why?
|
| Income | 3 | 2021 | 78 | 0.830 |
Why?
|
| Adult | 28 | 2023 | 8021 | 0.830 |
Why?
|
| Genotype | 5 | 2020 | 346 | 0.810 |
Why?
|
| Social Participation | 1 | 2022 | 12 | 0.810 |
Why?
|
| Leukoaraiosis | 3 | 2012 | 8 | 0.790 |
Why?
|
| Blood Glucose | 2 | 2022 | 108 | 0.790 |
Why?
|
| Crime Victims | 1 | 2022 | 28 | 0.790 |
Why?
|
| Analysis of Variance | 10 | 2017 | 275 | 0.770 |
Why?
|
| Clinical Protocols | 1 | 2022 | 59 | 0.770 |
Why?
|
| Anisotropy | 5 | 2023 | 53 | 0.760 |
Why?
|
| Longitudinal Studies | 13 | 2023 | 1366 | 0.740 |
Why?
|
| Diabetes Mellitus, Type 2 | 3 | 2018 | 184 | 0.730 |
Why?
|
| Optimism | 1 | 2021 | 2 | 0.730 |
Why?
|
| Cerebral Cortex | 4 | 2021 | 167 | 0.730 |
Why?
|
| Psychology | 1 | 2021 | 24 | 0.730 |
Why?
|
| Family Relations | 1 | 2021 | 14 | 0.730 |
Why?
|
| Social Segregation | 1 | 2020 | 7 | 0.710 |
Why?
|
| Social Environment | 1 | 2021 | 85 | 0.700 |
Why?
|
| Dementia, Vascular | 5 | 2020 | 45 | 0.700 |
Why?
|
| Antihypertensive Agents | 2 | 2020 | 72 | 0.700 |
Why?
|
| Racism | 1 | 2021 | 34 | 0.700 |
Why?
|
| Loneliness | 1 | 2021 | 57 | 0.690 |
Why?
|
| Cholesterol | 2 | 2019 | 55 | 0.690 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2022 | 88 | 0.690 |
Why?
|
| Social Capital | 1 | 2020 | 4 | 0.690 |
Why?
|
| Triglycerides | 1 | 2019 | 54 | 0.660 |
Why?
|
| Dyslipidemias | 1 | 2019 | 16 | 0.660 |
Why?
|
| Glomerular Filtration Rate | 1 | 2019 | 52 | 0.650 |
Why?
|
| Social Support | 1 | 2021 | 212 | 0.650 |
Why?
|
| Life Style | 1 | 2021 | 197 | 0.650 |
Why?
|
| Hyperinsulinism | 1 | 2019 | 4 | 0.650 |
Why?
|
| Mental Processes | 1 | 2019 | 20 | 0.640 |
Why?
|
| Cultural Diversity | 1 | 2019 | 29 | 0.630 |
Why?
|
| Prospective Studies | 13 | 2022 | 1748 | 0.630 |
Why?
|
| Community Health Services | 1 | 2019 | 33 | 0.620 |
Why?
|
| Insulin Resistance | 1 | 2019 | 53 | 0.620 |
Why?
|
| Neural Pathways | 9 | 2018 | 72 | 0.620 |
Why?
|
| Multilingualism | 1 | 2019 | 21 | 0.620 |
Why?
|
| Stress, Psychological | 1 | 2021 | 244 | 0.610 |
Why?
|
| Independent Living | 6 | 2022 | 308 | 0.610 |
Why?
|
| Phenotype | 2 | 2019 | 306 | 0.610 |
Why?
|
| Kidney | 1 | 2019 | 174 | 0.600 |
Why?
|
| Image Processing, Computer-Assisted | 4 | 2023 | 189 | 0.590 |
Why?
|
| Psychological Trauma | 1 | 2017 | 4 | 0.570 |
Why?
|
| Affect | 3 | 2013 | 60 | 0.550 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2018 | 380 | 0.540 |
Why?
|
| Serotonin | 4 | 2014 | 24 | 0.540 |
Why?
|
| Wounds and Injuries | 1 | 2017 | 45 | 0.540 |
Why?
|
| Individuality | 1 | 2016 | 25 | 0.520 |
Why?
|
| Metabolic Diseases | 1 | 2015 | 10 | 0.480 |
Why?
|
| Psychomotor Disorders | 1 | 2014 | 11 | 0.470 |
Why?
|
| Thinking | 1 | 2014 | 18 | 0.470 |
Why?
|
| Verbal Behavior | 5 | 2009 | 18 | 0.470 |
Why?
|
| Obesity | 4 | 2023 | 310 | 0.460 |
Why?
|
| Sex Factors | 6 | 2020 | 475 | 0.450 |
Why?
|
| Age Factors | 8 | 2020 | 788 | 0.450 |
Why?
|
| Surveys and Questionnaires | 10 | 2021 | 1201 | 0.440 |
Why?
|
| Frontal Lobe | 5 | 2018 | 83 | 0.440 |
Why?
|
| Vascular Diseases | 2 | 2013 | 45 | 0.430 |
Why?
|
| Alleles | 5 | 2023 | 209 | 0.430 |
Why?
|
| Memory, Episodic | 3 | 2018 | 116 | 0.430 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2012 | 37 | 0.410 |
Why?
|
| Health Surveys | 4 | 2021 | 90 | 0.410 |
Why?
|
| Models, Statistical | 3 | 2021 | 128 | 0.400 |
Why?
|
| Attention | 6 | 2023 | 139 | 0.400 |
Why?
|
| Galvanic Skin Response | 1 | 2011 | 7 | 0.390 |
Why?
|
| Gambling | 1 | 2011 | 8 | 0.390 |
Why?
|
| Case-Control Studies | 9 | 2023 | 582 | 0.380 |
Why?
|
| Dancing | 2 | 2021 | 12 | 0.380 |
Why?
|
| Models, Psychological | 1 | 2011 | 78 | 0.380 |
Why?
|
| Down Syndrome | 1 | 2011 | 10 | 0.370 |
Why?
|
| Biomarkers | 4 | 2021 | 581 | 0.370 |
Why?
|
| Brain Chemistry | 1 | 2011 | 44 | 0.370 |
Why?
|
| Crime | 2 | 2021 | 7 | 0.360 |
Why?
|
| Gastrointestinal Microbiome | 2 | 2023 | 176 | 0.360 |
Why?
|
| Basal Ganglia Cerebrovascular Disease | 1 | 2010 | 3 | 0.340 |
Why?
|
| Imaging, Three-Dimensional | 3 | 2016 | 229 | 0.340 |
Why?
|
| Sex Characteristics | 2 | 2022 | 123 | 0.340 |
Why?
|
| Chicago | 3 | 2021 | 902 | 0.340 |
Why?
|
| Reaction Time | 6 | 2023 | 115 | 0.330 |
Why?
|
| Neural Inhibition | 2 | 2014 | 8 | 0.320 |
Why?
|
| Apolipoprotein E4 | 3 | 2020 | 251 | 0.310 |
Why?
|
| Psychiatric Status Rating Scales | 7 | 2017 | 328 | 0.300 |
Why?
|
| Myelin Sheath | 2 | 2021 | 26 | 0.290 |
Why?
|
| Amnesia | 5 | 2020 | 27 | 0.290 |
Why?
|
| Learning | 2 | 2018 | 71 | 0.280 |
Why?
|
| Self Report | 3 | 2023 | 223 | 0.280 |
Why?
|
| Principal Component Analysis | 3 | 2021 | 26 | 0.270 |
Why?
|
| Language | 3 | 2021 | 68 | 0.270 |
Why?
|
| Visual Perception | 2 | 2020 | 35 | 0.270 |
Why?
|
| Hospitalization | 2 | 2019 | 316 | 0.270 |
Why?
|
| Young Adult | 7 | 2021 | 2043 | 0.260 |
Why?
|
| Reproducibility of Results | 4 | 2021 | 715 | 0.260 |
Why?
|
| Nerve Net | 5 | 2018 | 46 | 0.260 |
Why?
|
| Prevalence | 4 | 2021 | 466 | 0.260 |
Why?
|
| Pilot Projects | 3 | 2022 | 432 | 0.260 |
Why?
|
| DNA-Binding Proteins | 3 | 2023 | 274 | 0.250 |
Why?
|
| Problem Solving | 2 | 2009 | 48 | 0.240 |
Why?
|
| Temporal Lobe | 3 | 2018 | 86 | 0.230 |
Why?
|
| Discrimination Learning | 1 | 2004 | 1 | 0.230 |
Why?
|
| Color Perception | 1 | 2004 | 5 | 0.230 |
Why?
|
| Models, Neurological | 3 | 2018 | 25 | 0.230 |
Why?
|
| Arousal | 1 | 2004 | 50 | 0.220 |
Why?
|
| Severity of Illness Index | 5 | 2017 | 990 | 0.220 |
Why?
|
| Autistic Disorder | 2 | 2014 | 36 | 0.210 |
Why?
|
| Postmenopause | 1 | 2023 | 53 | 0.210 |
Why?
|
| Time Factors | 2 | 2019 | 1485 | 0.210 |
Why?
|
| Intelligence Tests | 2 | 2015 | 16 | 0.210 |
Why?
|
| Research Design | 2 | 2021 | 204 | 0.200 |
Why?
|
| Fraud | 1 | 2022 | 21 | 0.200 |
Why?
|
| Adolescent | 6 | 2021 | 2289 | 0.200 |
Why?
|
| Atherosclerosis | 1 | 2023 | 54 | 0.200 |
Why?
|
| Psychometrics | 2 | 2021 | 243 | 0.200 |
Why?
|
| Sensitivity and Specificity | 2 | 2019 | 511 | 0.200 |
Why?
|
| Socioeconomic Factors | 2 | 2021 | 308 | 0.200 |
Why?
|
| HIV Infections | 2 | 2021 | 481 | 0.190 |
Why?
|
| Geriatric Assessment | 3 | 2017 | 214 | 0.190 |
Why?
|
| Regression Analysis | 5 | 2018 | 266 | 0.190 |
Why?
|
| Awareness | 1 | 2002 | 45 | 0.190 |
Why?
|
| Facial Expression | 2 | 2012 | 15 | 0.190 |
Why?
|
| Cerebral Amyloid Angiopathy | 1 | 2023 | 114 | 0.190 |
Why?
|
| Data Interpretation, Statistical | 3 | 2022 | 83 | 0.190 |
Why?
|
| Social Identification | 1 | 2021 | 8 | 0.180 |
Why?
|
| Social Networking | 1 | 2021 | 11 | 0.180 |
Why?
|
| Genome-Wide Association Study | 2 | 2020 | 287 | 0.180 |
Why?
|
| Accelerometry | 2 | 2021 | 88 | 0.180 |
Why?
|
| Cerebral Small Vessel Diseases | 1 | 2021 | 12 | 0.180 |
Why?
|
| Emotions | 2 | 2012 | 87 | 0.180 |
Why?
|
| Treatment Outcome | 2 | 2022 | 3530 | 0.180 |
Why?
|
| Southeastern United States | 1 | 2020 | 14 | 0.180 |
Why?
|
| Midwestern United States | 1 | 2020 | 63 | 0.180 |
Why?
|
| Organ Size | 3 | 2023 | 105 | 0.180 |
Why?
|
| Wechsler Scales | 3 | 2006 | 10 | 0.170 |
Why?
|
| Mental Status Schedule | 3 | 2011 | 97 | 0.170 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2022 | 319 | 0.170 |
Why?
|
| Space Perception | 1 | 2020 | 24 | 0.170 |
Why?
|
| Judgment | 1 | 2019 | 9 | 0.170 |
Why?
|
| Acute Disease | 2 | 2012 | 204 | 0.170 |
Why?
|
| Cholesterol, HDL | 1 | 2019 | 26 | 0.170 |
Why?
|
| Cholesterol, LDL | 1 | 2019 | 31 | 0.170 |
Why?
|
| Disabled Persons | 1 | 2021 | 125 | 0.170 |
Why?
|
| Patient Selection | 1 | 2021 | 207 | 0.160 |
Why?
|
| Multivariate Analysis | 2 | 2017 | 319 | 0.160 |
Why?
|
| Interpersonal Relations | 1 | 2020 | 104 | 0.160 |
Why?
|
| Pandemics | 1 | 2021 | 257 | 0.160 |
Why?
|
| Atrophy | 2 | 2016 | 91 | 0.160 |
Why?
|
| Hypercholesterolemia | 1 | 2019 | 27 | 0.160 |
Why?
|
| Follow-Up Studies | 6 | 2019 | 1809 | 0.160 |
Why?
|
| Financing, Personal | 1 | 2018 | 20 | 0.160 |
Why?
|
| Emergencies | 1 | 2019 | 35 | 0.160 |
Why?
|
| Energy Intake | 1 | 2019 | 81 | 0.150 |
Why?
|
| Cognitive Reserve | 1 | 2019 | 39 | 0.150 |
Why?
|
| Genetic Variation | 1 | 2018 | 98 | 0.150 |
Why?
|
| Heterozygote | 1 | 2018 | 97 | 0.150 |
Why?
|
| Double-Blind Method | 3 | 2014 | 423 | 0.150 |
Why?
|
| Healthy Lifestyle | 1 | 2017 | 32 | 0.140 |
Why?
|
| Healthy Aging | 1 | 2017 | 15 | 0.140 |
Why?
|
| Obsessive-Compulsive Disorder | 1 | 2016 | 19 | 0.140 |
Why?
|
| Phobia, Social | 1 | 2016 | 13 | 0.140 |
Why?
|
| Motor Skills | 1 | 2017 | 54 | 0.130 |
Why?
|
| Neurodegenerative Diseases | 1 | 2018 | 117 | 0.130 |
Why?
|
| Predictive Value of Tests | 2 | 2011 | 492 | 0.130 |
Why?
|
| Self-Assessment | 2 | 2020 | 30 | 0.130 |
Why?
|
| Prognosis | 1 | 2019 | 818 | 0.130 |
Why?
|
| Gyrus Cinguli | 2 | 2016 | 17 | 0.130 |
Why?
|
| Bipolar Disorder | 1 | 2016 | 109 | 0.130 |
Why?
|
| Anxiety Disorders | 1 | 2017 | 170 | 0.130 |
Why?
|
| Urban Population | 1 | 2017 | 158 | 0.130 |
Why?
|
| Parkinson Disease | 2 | 2020 | 846 | 0.130 |
Why?
|
| Cytokines | 1 | 2017 | 240 | 0.120 |
Why?
|
| Cerebrovascular Circulation | 2 | 2014 | 35 | 0.120 |
Why?
|
| Inflammation | 3 | 2023 | 287 | 0.120 |
Why?
|
| Macromolecular Substances | 1 | 2014 | 6 | 0.120 |
Why?
|
| Statistics as Topic | 1 | 2014 | 116 | 0.120 |
Why?
|
| Animals | 2 | 2013 | 3824 | 0.110 |
Why?
|
| Axons | 1 | 2013 | 28 | 0.110 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2016 | 226 | 0.110 |
Why?
|
| Visual Cortex | 1 | 2012 | 7 | 0.100 |
Why?
|
| Auditory Cortex | 1 | 2012 | 3 | 0.100 |
Why?
|
| Oxygen | 1 | 2012 | 80 | 0.100 |
Why?
|
| Language Tests | 2 | 2021 | 33 | 0.100 |
Why?
|
| Photic Stimulation | 3 | 2020 | 38 | 0.100 |
Why?
|
| Task Performance and Analysis | 1 | 2011 | 49 | 0.100 |
Why?
|
| Reward | 1 | 2011 | 27 | 0.100 |
Why?
|
| Social Class | 2 | 2022 | 67 | 0.090 |
Why?
|
| Inositol | 1 | 2011 | 6 | 0.090 |
Why?
|
| Aspartic Acid | 1 | 2011 | 14 | 0.090 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2011 | 42 | 0.090 |
Why?
|
| Genes, MHC Class I | 1 | 2010 | 3 | 0.090 |
Why?
|
| HLA-B Antigens | 1 | 2010 | 9 | 0.090 |
Why?
|
| Antigen Presentation | 1 | 2010 | 14 | 0.090 |
Why?
|
| Disease Models, Animal | 1 | 2013 | 633 | 0.090 |
Why?
|
| Syndrome | 1 | 2010 | 81 | 0.080 |
Why?
|
| Weight Loss | 2 | 2023 | 126 | 0.080 |
Why?
|
| Pain Measurement | 1 | 2011 | 460 | 0.080 |
Why?
|
| Medicare | 2 | 2019 | 121 | 0.080 |
Why?
|
| HIV-1 | 1 | 2010 | 235 | 0.080 |
Why?
|
| Cues | 2 | 2011 | 50 | 0.080 |
Why?
|
| Neuropathology | 2 | 2019 | 84 | 0.080 |
Why?
|
| Comorbidity | 1 | 2009 | 497 | 0.070 |
Why?
|
| Adaptation, Physiological | 1 | 2007 | 52 | 0.070 |
Why?
|
| Cluster Analysis | 2 | 2011 | 44 | 0.070 |
Why?
|
| Functional Laterality | 1 | 2007 | 69 | 0.070 |
Why?
|
| Lewy Bodies | 2 | 2019 | 194 | 0.070 |
Why?
|
| Reading | 1 | 2006 | 42 | 0.070 |
Why?
|
| Dominance, Cerebral | 1 | 2004 | 16 | 0.060 |
Why?
|
| Evoked Potentials | 1 | 2004 | 14 | 0.060 |
Why?
|
| Limbic System | 1 | 2004 | 8 | 0.060 |
Why?
|
| Disease Progression | 2 | 2021 | 718 | 0.060 |
Why?
|
| Cross-Over Studies | 2 | 2014 | 64 | 0.050 |
Why?
|
| Reproduction | 1 | 2023 | 10 | 0.050 |
Why?
|
| Estrogens | 1 | 2023 | 26 | 0.050 |
Why?
|
| Baltimore | 1 | 2003 | 10 | 0.050 |
Why?
|
| Sample Size | 1 | 2003 | 20 | 0.050 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2023 | 51 | 0.050 |
Why?
|
| Age of Onset | 2 | 2013 | 97 | 0.050 |
Why?
|
| Infarction | 1 | 2023 | 30 | 0.050 |
Why?
|
| Social Determinants of Health | 1 | 2023 | 33 | 0.050 |
Why?
|
| Reference Values | 1 | 2003 | 201 | 0.050 |
Why?
|
| Maze Learning | 1 | 2002 | 16 | 0.050 |
Why?
|
| Boston | 1 | 2022 | 27 | 0.050 |
Why?
|
| Physical Therapy Modalities | 1 | 2022 | 73 | 0.050 |
Why?
|
| Cholinergic Antagonists | 1 | 2022 | 11 | 0.050 |
Why?
|
| Pregnancy | 1 | 2023 | 337 | 0.050 |
Why?
|
| Incidental Findings | 1 | 2021 | 14 | 0.050 |
Why?
|
| Psychotic Disorders | 1 | 2002 | 44 | 0.050 |
Why?
|
| Artificial Intelligence | 1 | 2022 | 31 | 0.050 |
Why?
|
| Delivery of Health Care | 1 | 2023 | 154 | 0.050 |
Why?
|
| Probability | 1 | 2021 | 91 | 0.050 |
Why?
|
| Factor Analysis, Statistical | 1 | 2021 | 63 | 0.050 |
Why?
|
| Caribbean Region | 1 | 2020 | 3 | 0.050 |
Why?
|
| South America | 1 | 2020 | 3 | 0.050 |
Why?
|
| Information Dissemination | 1 | 2021 | 19 | 0.050 |
Why?
|
| Amino Acids | 2 | 2010 | 18 | 0.040 |
Why?
|
| Ubiquitin-Conjugating Enzymes | 1 | 2020 | 4 | 0.040 |
Why?
|
| Lung | 1 | 2021 | 170 | 0.040 |
Why?
|
| New York | 1 | 2020 | 10 | 0.040 |
Why?
|
| Florida | 1 | 2020 | 22 | 0.040 |
Why?
|
| California | 1 | 2020 | 32 | 0.040 |
Why?
|
| Orientation | 1 | 2020 | 6 | 0.040 |
Why?
|
| Puerto Rico | 1 | 2019 | 13 | 0.040 |
Why?
|
| Walking | 1 | 2022 | 260 | 0.040 |
Why?
|
| Diabetes Complications | 1 | 2020 | 59 | 0.040 |
Why?
|
| Cerebral Ventricles | 1 | 2019 | 20 | 0.040 |
Why?
|
| Primary Prevention | 1 | 2019 | 33 | 0.040 |
Why?
|
| Diagnosis, Differential | 1 | 2020 | 370 | 0.040 |
Why?
|
| Amyloid | 1 | 2018 | 57 | 0.040 |
Why?
|
| Lewy Body Disease | 1 | 2019 | 99 | 0.040 |
Why?
|
| Amygdala | 1 | 2018 | 42 | 0.040 |
Why?
|
| Serial Learning | 1 | 2018 | 7 | 0.040 |
Why?
|
| Nervous System Diseases | 1 | 2019 | 120 | 0.040 |
Why?
|
| Health Status | 1 | 2019 | 227 | 0.040 |
Why?
|
| Perception | 1 | 2018 | 77 | 0.040 |
Why?
|
| Comoros | 1 | 2017 | 1 | 0.040 |
Why?
|
| Caloric Restriction | 1 | 2017 | 16 | 0.040 |
Why?
|
| Neurofibrillary Tangles | 1 | 2018 | 194 | 0.040 |
Why?
|
| Sphygmomanometers | 1 | 2017 | 3 | 0.030 |
Why?
|
| tau Proteins | 1 | 2018 | 227 | 0.030 |
Why?
|
| Massachusetts | 1 | 2017 | 20 | 0.030 |
Why?
|
| Autopsy | 1 | 2018 | 346 | 0.030 |
Why?
|
| Interleukin-1beta | 1 | 2017 | 57 | 0.030 |
Why?
|
| Interleukin-6 | 1 | 2017 | 79 | 0.030 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2017 | 193 | 0.030 |
Why?
|
| Czech Republic | 1 | 2014 | 1 | 0.030 |
Why?
|
| Body Mass Index | 1 | 2017 | 434 | 0.030 |
Why?
|
| Sampling Studies | 1 | 2014 | 29 | 0.030 |
Why?
|
| Thalamus | 1 | 2014 | 16 | 0.030 |
Why?
|
| Corpus Striatum | 1 | 2014 | 66 | 0.030 |
Why?
|
| Semantics | 1 | 2014 | 19 | 0.030 |
Why?
|
| Sensation | 1 | 2012 | 12 | 0.030 |
Why?
|
| HIV Long-Term Survivors | 1 | 2010 | 5 | 0.020 |
Why?
|
| HLA-A Antigens | 1 | 2010 | 14 | 0.020 |
Why?
|
| HIV Antigens | 1 | 2010 | 12 | 0.020 |
Why?
|
| HLA-C Antigens | 1 | 2010 | 10 | 0.020 |
Why?
|
| Protein Conformation | 1 | 2010 | 75 | 0.020 |
Why?
|
| Viral Load | 1 | 2010 | 74 | 0.020 |
Why?
|
| Haplotypes | 1 | 2010 | 57 | 0.020 |
Why?
|
| Positron-Emission Tomography | 1 | 2011 | 90 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2010 | 87 | 0.020 |
Why?
|
| Immunity, Innate | 1 | 2010 | 61 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2010 | 281 | 0.020 |
Why?
|
| Logistic Models | 1 | 2010 | 395 | 0.020 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2010 | 112 | 0.020 |
Why?
|
| Disability Evaluation | 1 | 2009 | 290 | 0.020 |
Why?
|
| Age Distribution | 1 | 2007 | 89 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2011 | 3524 | 0.010 |
Why?
|